Thank you for attending the interactive workshop!
This session challenged us to think critically about personalized treatment approaches in ulcerative colitis (UC) through the discussion of three complex patient cases. You’ll explore how factors such as age, disease severity, previous treatment response, growth delay, and reproductive planning influence the choice and timing of therapies. You can now watch the full recording on the Mosaic of Autoimmunity portal.
Simply log in to view the recording, complete the online course, and earn 1 CME credit.
This webinar is supported by an educational grant from Pfizer and it is part of the Innovations in Ulcerative Colitis Care: Personalized Treatment Pathways program.
Objectives:
- Critically evaluate treatment strategies in complex cases, including the use of advanced therapies.
- Strengthen shared decision-making practices to align treatment plans with individual patient goals.
- Reflect on multidisciplinary care needs in UC and identify strategies to improve long-term outcomes.
Faculty
Dr. Ayal Hirsch
Gastroenterologist
Prof. Uri Kopylov
Director of inflammatory bowel disease, IBD clinic
Prof. Uri Kopylov, MD, MBA is a Director of inflammatory bowel disease (IBD) clinic. He has an extensive research record in IBD and endoscopy, with multiple international collaborations and over 260 peer-reviewed publications. Prof. Kopylov is the secretary of the Israeli IBD society and the member of the Educational Committee of the European Crohn’s and Colitis Organization. He is a co-director of the Innovation Center in Gastroenterology in Sheba ARC focusing on IP-driven innovation in gastrointestinal diseases.
This webinar is supported by an educational grant from Pfizer and it is part of the Innovations in Ulcerative Colitis Care: Personalized Treatment Pathways program.
Dr. Ayal Hirsch is a gastroenterologist in Chicago, Illinois. He received his medical degree from Technion-Israel Inst of Technology Faculty of Medicine. Dr. Hirsch’s top areas of expertise are Viral Gastroenteritis, Crohn’s Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy. His clinical research consists of co-authoring 32 peer reviewed articles. Additionally, he has co-authored 29 articles in the study of Viral Gastroenteritis.